Literature DB >> 29496646

Viral etiology of prostate cancer: Genetic alterations and immune response. A literature review.

Syed Hani Abidi1, Fareena Bilwani2, Kulsoom Ghias3, Farhat Abbas4.   

Abstract

Prostate cancer is one of the most common cancers in men. Recent estimates suggest that over a million men are diagnosed with the disease annually. Prostate cancer pathogenesis involves both heritable and environmental factors. The molecular events involved in the development or progression of prostate cancer are still unclear. Recent body of literature highlights the role of viral infections in initiation or progression of prostate cancer. In this regard, certain viruses have been reported to interact with host proteins and bring about changes in genetic, immunological and inflammatory events that lead to initiation or progression of prostate cancer. We conducted a comprehensive PubMed database search to identify publications relevant to viruses associated with prostate cancer. In this review, we discuss the possible viral etiology of prostate cancer and evidence of viral-mediated genetic changes, and immune dysregulation involved in initiation or progression of prostate cancer.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Genetic; Immune system; Prostate cancer; Virus

Mesh:

Year:  2018        PMID: 29496646     DOI: 10.1016/j.ijsu.2018.02.050

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  8 in total

Review 1.  Systemic Treatment of Prostate Cancer in Elderly Patients: Current Role and Safety Considerations of Androgen-Targeting Strategies.

Authors:  Myrto Boukovala; Nicholas Spetsieris; Eleni Efstathiou
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

2.  Detection and characterization of latency stage of EBV and histopathological analysis of prostatic adenocarcinoma tissues.

Authors:  Khalid Ahmed; Alisalman Sheikh; Saira Fatima; Ghulam Haider; Kulsoom Ghias; Farhat Abbas; Nouman Mughal; Syed Hani Abidi
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

3.  Combined analysis and validation for DNA methylation and gene expression profiles associated with prostate cancer.

Authors:  Yanqiu Tong; Yang Song; Shixiong Deng
Journal:  Cancer Cell Int       Date:  2019-03-04       Impact factor: 5.722

4.  Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination.

Authors:  Hariyono Winarto; Muhammad Habiburrahman; Maya Dorothea; Andrew Wijaya; Kartiwa Hadi Nuryanto; Fitriyadi Kusuma; Tofan Widya Utami; Tricia Dewi Anggraeni
Journal:  PLoS One       Date:  2022-05-12       Impact factor: 3.752

Review 5.  Bone Health Management in the Continuum of Prostate Cancer Disease.

Authors:  Ettickan Boopathi; Ruth Birbe; Sunday A Shoyele; Robert B Den; Chellappagounder Thangavel
Journal:  Cancers (Basel)       Date:  2022-09-02       Impact factor: 6.575

6.  The Urinary Sarcosine/Creatinine Ratio is a Potential Diagnostic and Prognostic Marker in Prostate Cancer.

Authors:  Meng Wang; Lihui Zou; Jing Liang; Xin Wang; Dalei Zhang; Yuan Fang; Junhua Zhang; Fei Xiao; Ming Liu
Journal:  Med Sci Monit       Date:  2018-05-09

7.  XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma: Evidence based on 4306 patients and 4779 controls.

Authors:  Feng Qin; Sheng-Lin Gao; Kai Xu; Quan-Xin Su; Ze Zhang; Li Shi; Li-Jie Zhu; Li-Feng Zhang; Li Zuo
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

Review 8.  Health inequity drives disease biology to create disparities in prostate cancer outcomes.

Authors:  William G Nelson; Otis W Brawley; William B Isaacs; Elizabeth A Platz; Srinivasan Yegnasubramanian; Karen S Sfanos; Tamara L Lotan; Angelo M De Marzo
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.